| Literature DB >> 28223861 |
Syed Baker1, Azmath Pasha1, Sreedharamurthy Satish2.
Abstract
The present study emphasizes on synthesis of bimetallic silver-gold nanoparticles from cell free supernatant of Pseudomonas veronii strain AS41G inhabiting Annona squamosa L. The synthesized nanoparticles were characterized using hyphenated techniques with UV-Visible spectra ascertained absorbance peak between 400 and 800 nm. Possible interaction of biomolecules in mediating and stabilization of nanoparticles was depicted with Fourier transform infrared spectroscopy (FTIR). X-ray diffraction (XRD) displayed Bragg's peak conferring the 1 0 0, 1 1 1, 2 0 0, and 2 2 0 facets of the face centered cubic symmetry of nanoparticles suggesting that these nanoparticles were crystalline in nature. Size and shape of the nanoparticles were determined using Transmission electron microscopy (TEM) microgram with size ranging from 5 to 50 nm forming myriad shapes. Antibacterial activity of nanoparticles against significant human pathogens was conferred with well diffusion assay and its synergistic effect with standard antibiotics revealed 87.5% fold increased activity with antibiotic "bacitracin" against bacitracin resistant strains Bacillus subtilis, Escherichia coli and Klebsiella pneumoniae followed by kanamycin with 18.5%, gentamicin with 11.15%, streptomycin with 10%, erythromycin with 9.7% and chloramphenicol with 9.4%. Thus the study concludes with biogenic and ecofriendly route for synthesizing nanoparticles with antibacterial activity against drug resistant pathogens and attributes growing interest on endophytes as an emerging source for synthesis of nanoparticles.Entities:
Keywords: Bimetallic silver–gold nanoparticles; Biogenic; Broad spectrum antibiotics; Pseudomonas veronii AS41G; Synergistic activity
Year: 2015 PMID: 28223861 PMCID: PMC5310154 DOI: 10.1016/j.jsps.2015.06.011
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Figure 1UV spectra of bimetallic nanoparticles.
Figure 2FTIR and XRD pattern of bimetallic nanoparticles.
Representative of predicted functional groups.
| Peaks | Possible functional group | References |
|---|---|---|
| 3412 | Hydroxyl (–OH) | |
| 3180 | Hydroxyl (–OH) | |
| 2906 | Methyl (–CH3) primary group | |
| 2837 | Methylene (–CH2) secondary group | |
| 1641 | Amide I | |
| 1400 | C–H bonding | |
| 1101 | C–O–C bonding |
Figure 3TEM microgram of bimetallic nanoparticles.
Figure 5Proposed mechanistic approach of antibiotic conjugation with nanoparticles.
Figure 4Zone of inhibition in mm with antibiotics, nanoparticles and their synergistic activity. Note: Different bar graphs represent zone of inhibition against test pathogens. AB: Antibiotics, NP: Nanoparticles, AB+NP: Antibiotics in combination with nanoparticles
Mean zone of inhibition (mm) of different antibiotics, silver nanoparticles and combined antibiotics with silver nanoparticles.
| Pathogens | Antibiotics ( | SNP | Antibiotics + SNP ( | Fold increase % [( |
|---|---|---|---|---|
| Kanamycin | ||||
| 25 | 14 | 28 | 12 | |
| 24 | 13 | 27 | 12.5 | |
| 23 | 17 | 25 | 8.6 | |
| 12 | 11 | 15 | 25 | |
| Overall synergistic antibacterial effect: 16% | ||||
| Gentamicin | ||||
| 32 | 12 | 33 | 3.1 | |
| 26 | 18 | 30 | 15.3 | |
| 25 | 12 | 26 | 4.0 | |
| 18 | 10 | 22 | 22 | |
| Overall synergistic antibacterial effect: 11.15% | ||||
| Streptomycin | ||||
| 26 | 12 | 27 | 3.8 | |
| 25 | 13 | 30 | 20 | |
| 21 | 15 | 23 | 9.5 | |
| 28 | 10 | 30 | 7.1 | |
| Overall synergistic antibacterial effect: 10% | ||||
| Bacitracin | ||||
| – | 13 | 15 | 100 | |
| – | 16 | 19 | 100 | |
| 08 | 12 | 12 | 50 | |
| – | 09 | 09 | 100 | |
| Overall synergistic antibacterial effect: 87% | ||||
| Chloromphenicol | ||||
| 30 | 12 | 31 | 3.3 | |
| 30 | 14 | 32 | 6.6 | |
| 25 | 14 | 29 | 16 | |
| 17 | 09 | 19 | 11.7 | |
| Overall synergistic antibacterial effect: 9.4% | ||||
| Erythromycin | ||||
| 34 | 10 | 37 | 8.8 | |
| 25 | 15 | 27 | 8.0 | |
| 32 | 13 | 34 | 6.25 | |
| 12 | 09 | 14 | 16.0 | |
| Overall synergistic antibacterial effect: 9.7% | ||||